Skip to Main Content

Paper Details

Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting.
Cancer Discov
354
2016
CRISPR, Cas9, Gene, antiproliferative cell, cancer, cancer cell lines, cancer cells, cell, essential genes, genes, intergenic loci, mammalian cells, multiple genomic sites, single-guide RNAs, target loci
Author NameAffiliation
Barbara A WeirDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT
Barbara A WeirDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT
Francisca VazquezDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT
Maria Kost-AlimovaBroad Institute of Harvard and MIT
Andrew D CherniackBroad Institute of Harvard and MIT
Andrew D CherniackBroad Institute of Harvard and MIT
Gregory V KryukovDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT
Glenn S CowleyBroad Institute of Harvard and MIT
Levi A GarrawayDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Brigham and Women's Hospital and Harvard Medical School, Massachusetts. Harvard Medical School, Massachusetts. Howard Hughes Medical Institute
Levi A GarrawayDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Brigham and Women's Hospital and Harvard Medical School, Massachusetts. Harvard Medical School, Massachusetts. Howard Hughes Medical Institute
Kimberly StegmaierDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Massachusetts. Harvard Medical School, Massachusetts. Boston Children's Hospital
Kimberly StegmaierDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Massachusetts. Harvard Medical School, Massachusetts. Boston Children's Hospital
Charles W M RobertsBroad Institute of Harvard and MIT, Massachusetts. St. Jude Children's Research Hospital
Todd R GolubDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Massachusetts. Harvard Medical School, Massachusetts. Howard Hughes Medical Institute
Todd R GolubDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Massachusetts. Harvard Medical School, Massachusetts. Howard Hughes Medical Institute
Matthew MeyersonDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Massachusetts. Harvard Medical School, Harvard Medical School, Massachusetts. Center for Cancer Genome Discovery
Matthew MeyersonDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Massachusetts. Harvard Medical School, Harvard Medical School, Massachusetts. Center for Cancer Genome Discovery
David E RootBroad Institute of Harvard and MIT
David E RootBroad Institute of Harvard and MIT
Aviad TsherniakBroad Institute of Harvard and MIT, Massachusetts. aviad@broadinstitute.org.
Aviad TsherniakBroad Institute of Harvard and MIT, Massachusetts. aviad@broadinstitute.org.
William C HahnDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Brigham and Women's Hospital and Harvard Medical School, Massachusetts. Harvard Medical School, Massachusetts. Center for Cancer Genome Discovery, Massachusetts. aviad@broadinstitute.org.
William C HahnDana-Farber Cancer Institute, Massachusetts. Broad Institute of Harvard and MIT, Brigham and Women's Hospital and Harvard Medical School, Massachusetts. Harvard Medical School, Massachusetts. Center for Cancer Genome Discovery, Massachusetts. aviad@broadinstitute.org.
  • 1 - 23

Datasets

Release 1.2